1 HOUSE OF REPRESENTATIVES - FLOOR VERSION
2 STATE OF OKLAHOMA
3 1st Session of the 60th Legislature (2025)
4 ENGROSSED SENATE
BILL NO. 109 By: Stanley, Hicks, and Nice of
5 the Senate
6 and
7 Miller, Roe, Townley, West
(Tammy), Hefner, Ranson,
8 Provenzano, Munson, and
Schreiber of the House
9
10
11 [ health insurance - coverage of genetic testing and
12 cancer imaging - terms – exclusions – codification
13 - effective date ]
14
15
16 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
17 SECTION 1. NEW LAW A new section of law to be codified
18 in the Oklahoma Statutes as Section 6060.5b of Title 36, unless
19 there is created a duplication in numbering, reads as follows:
20 A. For the purposes of this section:
21 1. “Clinical utility” means clinical utility as defined
22 pursuant to Section 6060.5a of Title 36 of the Oklahoma Statutes;
23 2. “Evidence-based cancer imaging” means appropriate
24 preventative screening and imaging supported by evidence;
SB109 HFLR Page 1
BOLD FACE denotes Committee Amendments.

1 3. “Genetic testing for an inherited mutation” means multi-gene
2 testing for an inherited mutation associated with an increased risk
3 of cancer;
4 4. “Health benefit plan” means a health benefit plan as defined
5 pursuant to Section 6060.4 of Title 36 of the Oklahoma Statutes; and
6 5. “Health care provider” means any physician, hospital, or
7 other entity or person that is licensed or otherwise authorized in
8 this state to furnish health care services.
9 B. Any health benefit plan including the Oklahoma Employees
10 Insurance Plan that is offered, issued, or renewed in this state on
11 or after the effective date of this act shall provide coverage for:
12 1. Clinical genetic testing for an inherited gene mutation for
13 individuals with a personal or family history of cancer when such
14 test provides clinical utility and when ordered or recommended by a
15 health care provider in accordance with medical and scientific
16 evidence including, but not limited to:
17 a. the most recent version of the National Comprehensive
18 Cancer Network (NCCN) clinical practice
19 recommendations that are Category 2A or higher,
20 b. Centers for Medicare and Medicaid Services national
21 coverage determinations or Medicare administrative
22 contractor local coverage determinations, or
23 c. nationally recognized clinical practice guidelines;
24 and
SB109 HFLR Page 2
BOLD FACE denotes Committee Amendments.

1 2. Evidence-based cancer imaging for individuals with an
2 increased risk of cancer when such test provides clinical utility
3 and when ordered or recommended by a health care provider in
4 accordance with the most recent version of the NCCN clinical
5 practice recommendations that are Category 2A or higher, or in
6 accordance with other nationally recognized clinical practice
7 guidelines.
8 C. Coverage under this section shall not be subject to any
9 annual deductibles, copayments, or coinsurance limits as established
10 for all covered benefits under the health benefit plan.
11 D. If application of this section would result in health
12 savings account ineligibility under Section 223 of the Internal
13 Revenue Code of 1986, as amended, the provisions of this section
14 shall only apply to health savings accounts with qualified high
15 deductible health plans with respect to the deductible of such a
16 plan after the enrollee has satisfied the minimum deductible.
17 Provided, however, the provisions of this section shall apply to
18 items or services that are preventive care pursuant to Section
19 223(c)(2)(C) of the Internal Revenue Code of 1986, as amended,
20 regardless of whether the minimum deductible has been satisfied.
21 SECTION 2. This act shall become effective November 1, 2025.
22
23 COMMITTEE REPORT BY: COMMITTEE ON APPROPRIATIONS AND BUDGET, dated
04/16/2025 - DO PASS, As Amended and Coauthored.
24
SB109 HFLR Page 3
BOLD FACE denotes Committee Amendments.

[DELETED:  P B S    a M , ,eTyW)HrR , ,oM ,]
[DELETED:  P t C n]
[DELETED:  P]